Inventor
Bradford H. Hirth
Inventor
Littleton, MA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07CAcyclic or carbocyclic compounds14%
C12YEnzymes3%
C07HSugars1%
PatentTitleYear
11,098,056UDP glycosyltransferase inhibitors and methods of use20219,579,325'Modulators of TNF-α signaling'20179,546,161'Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors'20179,139,580'Glucosylceramide synthase inhibitors'20159,126,993'Glucosylceramide synthase inhibitors'20158,921,547'Modulators of TNF-α signaling'20148,779,163'Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors'20148,633,168'Inhibitors of S-adenosyl-L-methionine decarboxylase'20148,518,999'Modulators of TNF-αsignaling'20138,138,353'Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20127,763,738'Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20107,541,466'Tetrahydroisoquinoline derivatives for treating protein trafficking diseases'20097,265,228'Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20077,041,831'Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20067,034,031'Modulators of TNF-α signaling'20066,969,728'Modulators of TNF-α signaling'20056,855,830'Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20056,835,831'Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors'20046,410,533'Antibacterial compounds'20025,846,999'Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones'19985,780,505'Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones'19985,763,474'Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones'19985,605,909'Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds'19975,536,741'Diaminocyclobutene-3,4-diones'19965,536,731'Diaminocyclobutene-3,4-diones'19965,532,245'Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds'19965,530,025'Diaminocyclobutene-3,4-diones'19965,512,585'Diaminocyclobutene-3,4-diones'19965,466,712'Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones'19955,464,867'Diaminocyclobutene-3,4-diones'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1998Patents assigned to AMERICAN HOME PROD (11)· patent assignee history
1995–1997Based in Monmouth Junction, NJ, US· patent location history
1998–2017Based in Littleton, MA, US· patent location history
2002–2021Patents assigned to GENZYME CORP (19)· patent assignee history
2012–2014Patents assigned to HIRTH BRADFORD H (3)· patent assignee history
2012–2014Patents assigned to SIEGEL CRAIG (2)· patent assignee history
2013Patents assigned to BIEMANN HANS-PETER (1)· patent assignee history
2014Based in Waltham, MA, US· patent location history
2015Based in Framingham, MA, US· patent location history
2021Based in Bridgewater, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENZYME CORP | 19 | 2002–2021 |
| AMERICAN HOME PROD | 11 | 1995–1998 |
| HIRTH BRADFORD Hself | 3 | 2012–2014 |
| SIEGEL CRAIG | 2 | 2012–2014 |
| BIEMANN HANS-PETER | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Littleton, Massachusetts, US | 18 | 1998–2017 |
| Monmouth Junction, New Jersey, US | 8 | 1995–1997 |
| Framingham, Massachusetts, US | 2 | 2015 |
| Bridgewater, New Jersey, US | 1 | 2021 |
| Waltham, Massachusetts, US | 1 | 2014 |